Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrative analysis of gut microbiota and fecal metabolites in metabolic associated fatty liver disease patients

22 Aug 2022

Abstract excerpt

Objective Metabolic associated fatty liver disease (MAFLD) affects nearly a quarter of the world’s population. Our study aimed to characterize the gut microbiome and overall changes in the fecal and serum metabolomes in MAFLD patients. Methods Thirty-two patients diagnosed with MAFLD and 30 healthy individuals (control group, CG) were included in this study, the basic clinical characteristics and laboratory test...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diet and metabolism studies
Share to Gut microbiota and health
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36071958
DOI: 10.3389/fmicb.2022.969757

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrative analysis of gut microbiota and fecal metabolites in metabolic associated fatty liver disease patientsPMID 36071958Read ↗

Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver DiseaseSemantic proximity Read ↗

Fecal Metagenomics and Metabolomics Identifying Microbial Signatures in Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Fecal Metagenomics and Metabolomics Identifying Microbial Signatures in Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Bacteroides uniformis-generated hexadecanedioic acid ameliorates metabolic-associated fatty liver diseaseSemantic proximity Read ↗

Fatty Liver Disease and Gut Microbiota: A Comprehensive UpdateSemantic proximity Read ↗

Comparison of gut microbiota in male MAFLD patients with varying liver stiffnessSemantic proximity Read ↗

Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver DiseaseSemantic proximity Read ↗

Integrated analysis of the transcriptome and its interaction with the metabolome in metabolic associated fatty liver disease: Gut microbiome signatures, correlation networks, and effect of PNPLA3 genotype.Semantic proximity Read ↗

Multi-Omics Nutritional Approaches Targeting Metabolic-Associated Fatty Liver DiseaseSemantic proximity Read ↗

Gut Microbiota Patterns in Patients with Non-Alcoholic Fatty Liver Disease: A Comprehensive Assessment Using Three Analysis MethodsSemantic proximity Read ↗

The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategySemantic proximity Read ↗

The role of the gut microbiome and its metabolites in metabolic diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.